POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy

POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy

Guardado en:
Detalles Bibliográficos
Autores principales: Yan‐Xing Chen, Zi‐Xian Wang, Shu‐Qiang Yuan, Teng‐Jia Jiang, You‐Sheng Huang, Rui‐Hua Xu, Feng Wang, Qi Zhao
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/b915738d37a5444facd0e60cedcf9b20
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b915738d37a5444facd0e60cedcf9b20
record_format dspace
spelling oai:doaj.org-article:b915738d37a5444facd0e60cedcf9b202021-11-11T12:06:41ZPOLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy2001-132610.1002/ctm2.524https://doaj.org/article/b915738d37a5444facd0e60cedcf9b202021-09-01T00:00:00Zhttps://doi.org/10.1002/ctm2.524https://doaj.org/toc/2001-1326Yan‐Xing ChenZi‐Xian WangShu‐Qiang YuanTeng‐Jia JiangYou‐Sheng HuangRui‐Hua XuFeng WangQi ZhaoWileyarticleMedicine (General)R5-920ENClinical and Translational Medicine, Vol 11, Iss 9, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Yan‐Xing Chen
Zi‐Xian Wang
Shu‐Qiang Yuan
Teng‐Jia Jiang
You‐Sheng Huang
Rui‐Hua Xu
Feng Wang
Qi Zhao
POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
format article
author Yan‐Xing Chen
Zi‐Xian Wang
Shu‐Qiang Yuan
Teng‐Jia Jiang
You‐Sheng Huang
Rui‐Hua Xu
Feng Wang
Qi Zhao
author_facet Yan‐Xing Chen
Zi‐Xian Wang
Shu‐Qiang Yuan
Teng‐Jia Jiang
You‐Sheng Huang
Rui‐Hua Xu
Feng Wang
Qi Zhao
author_sort Yan‐Xing Chen
title POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
title_short POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
title_full POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
title_fullStr POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
title_full_unstemmed POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
title_sort pole/pold1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
publisher Wiley
publishDate 2021
url https://doaj.org/article/b915738d37a5444facd0e60cedcf9b20
work_keys_str_mv AT yanxingchen polepold1mutationinnonexonucleasedomainmattersforpredictingefficacyofimmunecheckpointinhibitortherapy
AT zixianwang polepold1mutationinnonexonucleasedomainmattersforpredictingefficacyofimmunecheckpointinhibitortherapy
AT shuqiangyuan polepold1mutationinnonexonucleasedomainmattersforpredictingefficacyofimmunecheckpointinhibitortherapy
AT tengjiajiang polepold1mutationinnonexonucleasedomainmattersforpredictingefficacyofimmunecheckpointinhibitortherapy
AT youshenghuang polepold1mutationinnonexonucleasedomainmattersforpredictingefficacyofimmunecheckpointinhibitortherapy
AT ruihuaxu polepold1mutationinnonexonucleasedomainmattersforpredictingefficacyofimmunecheckpointinhibitortherapy
AT fengwang polepold1mutationinnonexonucleasedomainmattersforpredictingefficacyofimmunecheckpointinhibitortherapy
AT qizhao polepold1mutationinnonexonucleasedomainmattersforpredictingefficacyofimmunecheckpointinhibitortherapy
_version_ 1718439070825185280

Ejemplares similares